PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Company Information
Industry
Laboratory Analytical Instruments
SIC Code
3826
Entity Type
operating
SEC Category
Accelerated filer
State of Incorporation
DE
Business Address
1305 O'BRIEN DRIVE, MENLO PARK, CA, 94025
Mailing Address
1305 O'BRIEN DRIVE, MENLO PARK, CA, 94025
Phone
650-521-8000
Fiscal Year End
1231
EIN
161590339
Financial Overview
FY2025
$179.91M
Cash & Equivalents
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| SCHEDULE 13G/A Passive ownership amendment | March 27, 2026 | View on SEC |
| 8-K Current report of material events | March 6, 2026 | View on SEC |
| 8-K Current report of material events | March 5, 2026 | View on SEC |
| 4 Insider stock transaction report | March 5, 2026 | View on SEC |
| 3 Initial insider ownership report | March 5, 2026 | View on SEC |
| 4 Insider stock transaction report | March 4, 2026 | View on SEC |
| 4 Insider stock transaction report | March 4, 2026 | View on SEC |
| 4 Insider stock transaction report | March 4, 2026 | View on SEC |
| 4 Insider stock transaction report | March 3, 2026 | View on SEC |
| 4 Insider stock transaction report | March 3, 2026 | View on SEC |
Material Events
8-K
Strategy Change
February 2, 2026
High Impact
- Sharpened strategic focus on high-growth long-read sequencing market.
- Significant financial strengthening with $48.1 million net cash infusion.
Insider Trading
STRONG SELL
3 insiders
9 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 3826)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.